Division of Nephrology, RWTH Aachen University, 52074 Aachen, Germany.
Department of Biochemistry, Cardiovascular Research Institute Maastricht, 6200MD Maastricht, The Netherlands.
Int J Mol Sci. 2019 Feb 19;20(4):896. doi: 10.3390/ijms20040896.
Vitamin K is an essential bioactive compound required for optimal body function. Vitamin K can be present in various isoforms, distinguishable by two main structures, namely, phylloquinone (K1) and menaquinones (K2). The difference in structure between K1 and K2 is seen in different absorption rates, tissue distribution, and bioavailability. Although differing in structure, both act as cofactor for the enzyme gamma-glutamylcarboxylase, encompassing both hepatic and extrahepatic activity. Only carboxylated proteins are active and promote a health profile like hemostasis. Furthermore, vitamin K2 in the form of MK-7 has been shown to be a bioactive compound in regulating osteoporosis, atherosclerosis, cancer and inflammatory diseases without risk of negative side effects or overdosing. This review is the first to highlight differences between isoforms vitamin K1 and K2 by means of source, function, and extrahepatic activity.
维生素 K 是一种必需的生物活性化合物,对身体功能的最佳状态至关重要。维生素 K 可以以多种形式存在,其区别主要在于两种结构,即叶绿醌(K1)和甲萘醌(K2)。K1 和 K2 的结构差异体现在不同的吸收率、组织分布和生物利用度上。虽然结构不同,但两者都作为 γ-谷氨酰羧化酶的辅助因子,包括肝内和肝外活性。只有羧化蛋白具有活性,并促进止血等健康特征。此外,MK-7 形式的维生素 K2 已被证明是一种具有生物活性的化合物,可调节骨质疏松症、动脉粥样硬化、癌症和炎症性疾病,而没有负面副作用或过量的风险。本综述是首次通过来源、功能和肝外活性来强调维生素 K1 和 K2 两种异构体的差异。